Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Recent & Breaking News (NYSE:PFE)

Immuno-Oncology Game-Changers from Big Pharma and Small Biotechs

Equities.com June 30, 2014

Triumeq® (dolutegravir/abacavir/lamivudine) single-tablet regimen receives positive CHMP opinion in Europe for the treatment of HIV

PR Newswire June 27, 2014

Eliquis® (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE

Business Wire June 27, 2014

Pfizer Declares 26-Cent Third-Quarter 2014 Dividend

Business Wire June 26, 2014

James C. Smith Elected to Pfizer's Board of Directors

Business Wire June 26, 2014

Pfizer Invites Public to View and Listen to Webcast of July 29 Conference Call with Analysts

Business Wire June 24, 2014

IPO Report: KineMed (KNMD)

Equities.com June 24, 2014

Two-Year Results From Pfizer's XELJANZ® (Tofacitinib Citrate) ORAL Start Study Published in The New England Journal of Medicine

Business Wire June 18, 2014

Pfizer And Cellectis Enter Into Global Strategic Cancer Immunotherapy Collaboration

Business Wire June 18, 2014

Pfizer Announces Submission of Biologics License Application to the FDA for Investigational Meningococcal B Vaccine

Business Wire June 17, 2014

Xybion Announces Pristima Selected by Pfizer Inc. for its Drug Safety R&D Data Management Solution

Business Wire June 16, 2014

Medtronic Paying $43 Billion for Covidien, Moving HQ to Ireland

Equities.com June 16, 2014

Pfizer Opens New State-of-the-Art Research and Development Site in Cambridge, Massachusetts

Business Wire June 16, 2014

How the Lack of R&D at Big Pharma Is Boosting Small Biotechs

Equities.com June 14, 2014

ViiV Healthcare announces new collaboration with Janssen to investigate single-tablet regimen for maintenance treatment of HIV-1

PR Newswire June 12, 2014

Biotech Investors Need to Focus on Catalysts

Equities.com June 11, 2014

Understanding the Impact of Clinical Trials on Shareholder Value

Equities.com June 11, 2014

Pfizer Announces Over 10 Abstracts for XELJANZ® (Tofacitinib Citrate) in Rheumatoid Arthritis to be Presented at the European League Against Rheumatism (EULAR) 2014 Annual Meeting

Business Wire June 11, 2014

Prescription for Profit: Pharma-Biotech Industry Continues Mega-Billion Dollar Merger & Acquisition Binge, an Industrial Info News Alert

Marketwired June 11, 2014

National Survey Identifies Potential Barriers to HIV Treatment Use in U.S.

PR Newswire June 10, 2014